Analysts expect Abivax S.A. to report revenue of 4.82 M for 2026, against a range of 4.38 M to 5.27 M. The most recent reported year, 2025, came in at 5.33 M, a 29.0% miss against the 7.51 M consensus.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 2.29 M | 106,230.00 | 4.95 M | 14.10 M | 5.33 M | - | - | ||
| High Estimate | 761,160.35 | 1.83 M | 467,852.97 | 9.94 M | 8.07 M | 5.27 M | 107.35 M | ||
| Low Estimate | 633,649.61 | 1.55 M | 432,097.93 | 9.03 M | 6.95 M | 4.38 M | 94.09 M | ||
| Consensus Estimate | 697,404.98 | 1.69 M | 449,975.45 | 9.48 M | 7.51 M | 4.82 M | 100.72 M |
Analysts expect Abivax S.A. to report earnings per share of -4.55 for 2026, against a range of -4.78 to -4.32. The most recent reported year, 2025, came in at -5.53, a 26.5% miss against the -4.37 consensus.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -2.89 | -3.52 | -3.68 | -3.13 | -5.53 | - | - | ||
| High Estimate | -3.24 | -2.71 | -1.89 | -2.73 | -4.09 | -4.32 | -3.55 | ||
| Low Estimate | -3.60 | -3.11 | -2.21 | -2.91 | -4.65 | -4.78 | -4.31 | ||
| Consensus Estimate | -3.42 | -2.91 | -2.05 | -2.82 | -4.37 | -4.55 | -3.93 |
Pull Wall Street consensus for Abivax S.A. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ABVX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ABVX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ABVX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();